See also this year's filing and all EDGAR filings for this company.
PDF Report 0001173313_2023_ABVC_BIOPHARMA_INC.pdf
Logs
Graph
Absolute values for 0001173313, ABVC BIOPHARMA INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,987,247 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 573,978 |
| 3 | remainder_Assets | 6,294,250 |
| 4 | LiabilitiesCurrent | 5,819,529 |
| 5 | LiabilitiesNoncurrent | 791,827 |
| 6 | remainder_Liabilities | 7,980 |
| 7 | CostOfGoodsAndServicesSold | 286,415 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,067,545 |
| 9 | ResearchAndDevelopmentExpense | 2,693,457 |
| 10 | remainder_Expenses | 7,834,556 |
| 11 | remainder_Revenues | 969,783 |
| 12 | remainder_NetIncome | -400,184 |
| 13 | remainder_ComprehensiveNetIncome | -133,397 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 9,855,475 |
| 1 | Liabilities | 6,619,336 |
| 2 | Expenses | 16,881,973 |
| 3 | Revenues | 969,783 |
| 4 | StockholdersEquity | 3,236,139 |
| 5 | NetIncome | -16,312,374 |
| 6 | ComprehensiveNetIncome | -16,379,072 |
| 7 | BaseVar | 17,430,074 |
| 8 | EconomicCapitalRatio | -1.31 |
Edgar->Model Mapping
Feature Distribution
Change over Time
